Andrew Hore

Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.

Aquis weekly movers: Hydrogen Utopia confirms standard switch

AIM weekly movers: GENinCode progresses towards US launch

AIM movers: One Media IP bets revenue expectations and Mosman flow rate for Cinnabar

AIM movers: Itaconix board appointment and ex-dividend

Dignity bid approach

Ryanair upgrades expectations

HeiQ forecasts slashed

AIM movers: Corcel farm-out and United Oil & Gas disappointment

AIM movers: GENinCode gains US lab approval and Bidstack dispute

New Year prospects: Windward Ltd

New Year prospects: ProCook Group

Aquis weekly movers: Invinity Energy Systems upgrade

New Year prospects: Blackbird

AIM weekly movers: Indicative proposals for Applied Graphene Materials

New Year prospects: CMO Group

Positive trial data for Celadon Pharmaceuticals

AIM movers: Catenae Innovations returns from suspension and Pantheon Resources share price slump

Catalyst Media NAV trebles

AIM movers: Allergy Therapeutics accounts delayed and ex-dividends

New Year prospects: Tribal Group

New Year prospects: Cake Box

AIM movers: Polarean Imaging gains FDA approval

Argo Blockchain secures future

New Year prospects: Dianomi

New Year prospects: Actual Experience

Aquis weekly movers: Hydrogen Utopia delays Main Market switch

New Year prospects: Victoria

New Year prospects: Portmeirion Group

AIM weekly movers: Tekmar recovers but no news on strategic investor

New Year prospects: Likewise Group

Xpeng – the Tesla rival whose shares have rallied 315% in two months

23/11/2020

‘End of Austerity’ promise hashed out during PMQs

10/10/2018

Brexit: 5,000 City jobs could leave UK

10/10/2018

Advanced Oncotherapy shares soar after cancer treatment milestone

10/10/2018

Two reasons Travelodge backers can expect sleepless nights

24/07/2020